ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences

Rhea-AI Summary

ImmunoGen, Inc. (Nasdaq: IMGN) has announced upcoming webcasts of presentations at key investor conferences. The events include the Cowen 43rd Annual Health Care Conference on March 8 at 9:10am ET and the Barclays Global Healthcare Conference on March 15 at 10:15am ET. Live webcasts will be available via the company’s website, with replays accessible afterward. ImmunoGen is focused on developing advanced antibody-drug conjugates (ADCs) to improve cancer treatment outcomes and enhance patient comfort, embodying their mission to TARGET A BETTER NOW™.

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

• Cowen 43^rd Annual Health Care Conference

March 8 at 9:10am ET

• Barclays Global Healthcare Conference

March 15 at 10:15am ET

A webcast of each presentation will be accessible through the “Investors and Media” section of the Company’s website, www.immunogen.com. Following the live webcast, a replay will be available at the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005317/en/

INVESTOR RELATIONS

ImmunoGen

Anabel Chan

781-895-0600

anabel.chan@immunogen.com

MEDIA

ImmunoGen

Courtney O'Konek

781-895-0600

courtney.okonek@immunogen.com

OR

FTI Consulting

Robert Stanislaro

212-850-5657

robert.stanislaro@fticonsulting.com

Source: ImmunoGen, Inc.

FAQ

What are the dates for ImmunoGen's upcoming investor conferences?

ImmunoGen will present at the Cowen 43rd Annual Health Care Conference on March 8 at 9:10am ET and at the Barclays Global Healthcare Conference on March 15 at 10:15am ET.

How can I watch ImmunoGen's conference presentations?

You can watch the live webcasts of ImmunoGen's presentations on their website, with replays available afterward.

What is ImmunoGen's focus in cancer treatment?

ImmunoGen specializes in developing next-generation antibody-drug conjugates (ADCs) to enhance cancer treatment and improve patient outcomes.

What is the goal of ImmunoGen's mission?

ImmunoGen's mission is to TARGET A BETTER NOW™, providing targeted therapies that improve anti-tumor activity while maintaining favorable tolerability for patients.

Where can I find more information about ImmunoGen?

More information about ImmunoGen, including its products and mission, can be found on their official website at www.immunogen.com.